Trials / Completed
CompletedNCT03742271
Evaluation of Senofilcon A With New UV-blocker on a Neophyte Population
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 130 (actual)
- Sponsor
- Johnson & Johnson Vision Care, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 39 Years
- Healthy volunteers
- Accepted
Summary
This is a 5-visit, single-arm, open-label, dispensing study. Each subject will be bilaterally fit with the test article for approximately 4 weeks of reusable daily wear with lens replacement occurring 2-weeks after initial dispensing. After 4 weeks of study lens wear, subjects will return to their habitual spectacles for one week.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | senofilcon A | TEST Lens |
Timeline
- Start date
- 2018-10-30
- Primary completion
- 2019-03-31
- Completion
- 2019-03-31
- First posted
- 2018-11-15
- Last updated
- 2020-03-13
- Results posted
- 2020-03-13
Locations
11 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03742271. Inclusion in this directory is not an endorsement.